Prosper Junior Bakiny
TMFPBakiny
Prosper Junior Bakiny is a contributing Motley Fool healthcare analyst covering biotechnology, pharmaceuticals, and healthcare stocks. Before The Motley Fool, Prosper wrote about investing topics ranging from stock market news to private equity for various companies. He holds a master’s degree in corporate finance from the University of Maryland Global Campus.
Recent Articles by Prosper Junior Bakiny

Dec 23, 2024
by Prosper Junior Bakiny
2 Excellent Dividend Stocks to Buy on the Dip

Dec 22, 2024
by Prosper Junior Bakiny
Is AstraZeneca Stock a Buy?

Dec 20, 2024
by Prosper Junior Bakiny
Is Moderna Stock a Buy?

Dec 20, 2024
by Prosper Junior Bakiny
Where Will Summit Therapeutics Be in 5 Years?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.